SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-068339
Filing Date
2024-06-04
Accepted
2024-06-04 17:26:14
Documents
2
Period of Report
2024-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416264-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2416264-1_3seq1.xml 3 1631
2 EXHIBIT 24 tm2416264-1_ex24.htm EX-24 8086
  Complete submission text file 0001104659-24-068339.txt   11232
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Issuer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OCULAR THERAPEUTIX, INC. 15 CROSBY DRIVE BEDFORD MA 01730
Business Address
Waheed Nadia (Reporting) CIK: 0002023884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36554 | Film No.: 241019582